357 related articles for article (PubMed ID: 29330079)
1. Impact of Platelet Transfusion on Intracerebral Hemorrhage in Patients on Antiplatelet Therapy-An Analysis Based on Intracerebral Hemorrhage Score.
Arnone GD; Kumar P; Wonais MC; Esfahani DR; Campbell-Lee SA; Charbel FT; Amin-Hanjani S; Alaraj A; Seicean A; Mehta AI
World Neurosurg; 2018 Mar; 111():e895-e904. PubMed ID: 29330079
[TBL] [Abstract][Full Text] [Related]
2. Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage.
Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; DeRosa PA; Landes E; Lei S; Khandji J; Gutbrod S; Connolly ES
Neurol Res; 2010 Sep; 32(7):706-10. PubMed ID: 20819399
[TBL] [Abstract][Full Text] [Related]
3. Thrombocytopenia and Clinical Outcomes in Intracerebral Hemorrhage: A Retrospective Multicenter Cohort Study.
Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
Stroke; 2021 Jan; 52(2):611-619. PubMed ID: 33430632
[TBL] [Abstract][Full Text] [Related]
4. Variability in the Use of Platelet Transfusion in Patients with Intracerebral Hemorrhage: Observations from the Ethnic/Racial Variations of Intracerebral Hemorrhage Study.
Guerrero WR; Gonzales NR; Sekar P; Kawano-Castillo J; Moomaw CJ; Worrall BB; Langefeld CD; Martini SR; Flaherty ML; Sheth KN; Osborne J; Woo D
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1974-1980. PubMed ID: 28669659
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
[TBL] [Abstract][Full Text] [Related]
6. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage.
Creutzfeldt CJ; Weinstein JR; Longstreth WT; Becker KJ; McPharlin TO; Tirschwell DL
J Stroke Cerebrovasc Dis; 2009; 18(3):221-8. PubMed ID: 19426894
[TBL] [Abstract][Full Text] [Related]
7. Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage.
Magid-Bernstein J; Beaman CB; Carvalho-Poyraz F; Boehme A; Hod EA; Francis RO; Elkind MSV; Agarwal S; Park S; Claassen J; Connolly ES; Roh D
Blood; 2021 May; 137(19):2699-2703. PubMed ID: 33649761
[TBL] [Abstract][Full Text] [Related]
8. The effect of platelet transfusion on functional independence and mortality after antiplatelet therapy associated spontaneous intracerebral hemorrhage: A systematic review and meta-analysis.
Morris NA; Patel N; Galvagno SM; Ludeman E; Schwartzbauer GT; Pourmand A; Tran QK
J Neurol Sci; 2020 Oct; 417():117075. PubMed ID: 32763508
[TBL] [Abstract][Full Text] [Related]
9. Statistical analysis plan for the PlAtelet Transfusion in Cerebral Haemorrhage (PATCH) trial: a multicentre randomised controlled trial.
Baharoglu MI; Al-Shahi Salman R; Cordonnier C; de Haan RJ; Roos YB
Trials; 2016 Aug; 17():379. PubMed ID: 27484334
[TBL] [Abstract][Full Text] [Related]
10. Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes.
Khan NI; Siddiqui FM; Goldstein JN; Cox M; Xian Y; Matsouaka RA; Heidenreich PA; Peterson ED; Bhatt DL; Fonarow GC; Schwamm LH; Smith EE
Stroke; 2017 Jul; 48(7):1810-1817. PubMed ID: 28596454
[TBL] [Abstract][Full Text] [Related]
11. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
Baharoglu MI; Cordonnier C; Al-Shahi Salman R; de Gans K; Koopman MM; Brand A; Majoie CB; Beenen LF; Marquering HA; Vermeulen M; Nederkoorn PJ; de Haan RJ; Roos YB;
Lancet; 2016 Jun; 387(10038):2605-2613. PubMed ID: 27178479
[TBL] [Abstract][Full Text] [Related]
12. Aspirin Response Test role in platelet transfusion following intracerebral hemorrhage.
Engel-Haber E; Horev A; Chablani P; Bornstein NM; Jadhav A; Jovin TG; Reddy V; Hammer MD
Clin Neurol Neurosurg; 2015 Oct; 137():12-4. PubMed ID: 26117592
[TBL] [Abstract][Full Text] [Related]
13. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage.
Naidech AM; Jovanovic B; Liebling S; Garg RK; Bassin SL; Bendok BR; Bernstein RA; Alberts MJ; Batjer HH
Stroke; 2009 Jul; 40(7):2398-401. PubMed ID: 19443791
[TBL] [Abstract][Full Text] [Related]
14. Prior antiplatelet therapy is not associated with larger hematoma volume or hematoma growth in intracerebral hemorrhage.
van Ginneken V; Engel P; Fiebach JB; Audebert HJ; Nolte CH; Rocco A
Neurol Sci; 2018 Apr; 39(4):745-748. PubMed ID: 29441487
[TBL] [Abstract][Full Text] [Related]
15. Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage.
Naidech AM; Liebling SM; Rosenberg NF; Lindholm PF; Bernstein RA; Batjer HH; Alberts MJ; Kwaan HC
Neurocrit Care; 2012 Feb; 16(1):82-7. PubMed ID: 21837536
[TBL] [Abstract][Full Text] [Related]
16. Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy.
Washington CW; Schuerer DJ; Grubb RL
J Trauma; 2011 Aug; 71(2):358-63. PubMed ID: 21825939
[TBL] [Abstract][Full Text] [Related]
17. Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis.
Camps-Renom P; Alejaldre-Monforte A; Delgado-Mederos R; Martínez-Domeño A; Prats-Sánchez L; Pascual-Goñi E; Martí-Fàbregas J
Eur J Neurol; 2017 Feb; 24(2):302-308. PubMed ID: 27801531
[TBL] [Abstract][Full Text] [Related]
18. Red Blood Cell Transfusions Are Not Associated With Incident Complications or Poor Outcomes in Patients With Intracerebral Hemorrhage.
Carvalho Poyraz F; Boehme A; Cottarelli A; Eisler L; Elkind MSV; Ghoshal S; Agarwal S; Park S; Claassen J; Connolly ES; Hod EA; Roh DJ
J Am Heart Assoc; 2023 Jun; 12(11):e028816. PubMed ID: 37232240
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage.
Xian Y; Zhang S; Inohara T; Grau-Sepulveda M; Matsouaka RA; Peterson ED; Piccini JP; Smith EE; Sheth KN; Bhatt DL; Fonarow GC; Schwamm LH
JAMA Netw Open; 2021 Feb; 4(2):e2037438. PubMed ID: 33591368
[TBL] [Abstract][Full Text] [Related]
20. Red Blood Cell Transfusions and Outcomes After Intracerebral Hemorrhage.
Roh DJ; Carvalho Poyraz F; Magid-Bernstein J; Elkind MSV; Agarwal S; Park S; Claassen J; Connolly ES; Hod E; Murthy SB
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105317. PubMed ID: 32992186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
